HC Wainwright & Co. analyst Yi Chen downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral and maintains $6 price target.
HC Wainwright & Co. Downgrades Alimera Sciences to Neutral, Maintains $6 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.